4.2 Article

Knee Osteoarthritis and Risk of Hypertension: A Longitudinal Cohort Study

期刊

REJUVENATION RESEARCH
卷 21, 期 1, 页码 15-21

出版社

MARY ANN LIEBERT, INC
DOI: 10.1089/rej.2017.1917

关键词

osteoarthritis; hypertension; cardiovascular disease; epidemiology

资金

  1. National Institutes of Health, a branch of the Department of Health and Human Services [N01-AR-2-2258, N01-AR-2-2259, N01-AR-22260, N01-AR-2-2261, N01-AR-2-2262]
  2. Merck Research Laboratories
  3. Novartis Pharmaceuticals Corporation
  4. GlaxoSmithKline
  5. Pfizer, Inc.

向作者/读者索取更多资源

Although previous research has indicated an association between osteoarthritis (OA) and cardiovascular disease, it remains unclear whether people with OA are at greater risk of developing hypertension. The aim of this study was to answer this uncertainity. We used the data of the Osteoarthritis Initiative, an ongoing public and private longitudinal study including people at higher risk of OA or having knee OA. Knee OA was defined through radiological and clinical assessment. Incident hypertension was defined as a systolic blood pressure 140mmHg and/or a diastolic value 90mmHg. Multivariate Cox's regression analyses were constructed considering the presence of knee OA as the exposure and incident hypertension as the outcome during a 96-month follow-up interval. A total of 3558 people with normative blood pressure values at baseline were analyzed (1930 OA/1628 controls). Incidence of hypertension within the follow-up interval was significantly higher in people with knee OA than in those without (60/[1000 person-years] vs. 55/[1000 person-years]; p<0.0001). After adjusting for 13 confounders, people with knee OA had a 13% higher chance of developing hypertension (hazard ratio=1.13; 95% confidence interval: 1.01-1.26; p=0.03). Propensity score analysis did not alter these conclusions. In conclusion, this is the first longitudinal data analysis to demonstrate that people with knee OA have a higher chance of developing hypertension than those without OA. Our data suggest that monitoring blood pressure and prescribing health promotion interventions may be warranted among people with OA to mitigate the potential onset and adverse consequences of hypertension.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据